US increases Pfizer and Moderna COVID-19 vaccine orders
The agreements take the number of doses ordered from the two authorized vaccines up to 600 million: enough to vaccinate most of the adult population.
The US has exercised its option for an additional 100 million doses of the Pfizer/BioNTech COVID-19 vaccine: bringing the total to 300 million doses.
Consistent with the agreements for the prior 200 million doses, the US government will pay $1.95bn for the additional 100 million doses.
Pfizer’s facility in Kalamazoo, Michigan remains the primary manufacturing site of the Pfizer-BioNTech COVID-19 Vaccine in the US. President Joe Biden is due to visit the site on Thursday (February 18).
Similarly, the Government has purchased an additional 100 million doses of Modern'as vaccine, bringing the order up to 300 million doses.
To date, Moderna has supplied 41 million doses in the country, with more than 22 million people having received the vaccine. The total of the first 100 million doses will be delivered across the first quarter of 2021 and the second set of 100 million doses in May 2021. It pledges to deliver the latest order by the end of July.
Doses will be manufactured in the US.